Delivering a baby increases, then lowers, risk of breast cancer: Study
Researchers found that the breast cancer risk peaks 4.6 years after a woman’s most recent birth but then begins to fall
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Research
J&J says its psoriasis drug superior to Novartis treatment: Study
Psoriasis is a chronic condition that causes an overproduction of skin cells, resulting in inflamed, red lesions or plaques, which…
Novel antibacterial drugs developed at University of Eastern Finland
In the era of increased antibiotic resistance, it is necessary to focus on developing new antibacterial agents
Novartis abandons effort for US approval of biosimilar rituximab
The decision comes after the US Food and Drug Administration (FDA) sought additional information to support the company’s…
Anesthesia in early childhood not tied to developmental problems
Young children who had surgery under general anesthesia were no more likely than their siblings who weren’t exposed to anesthesia…
Lilly says diabetes drug Trulicity reduces heart risks in trial
The company did not provide any details on the magnitude of risk reduction seen in the so-called outcomes trial
Ciprofloxacin has dramatic effects on mitochondrial genome
While they are generally well tolerated, some patients receiving fluoroquinolones develop severe health problems, among them…
Abbott’s Portico transcatheter aortic valve reduces severe aortic stenosis
Patients who received a Portico aortic heart valve had low rates of stroke, death and valve leak; and improved quality of life
Our research aims to develop low-cost efficient anti-cancer therapeutic options: Dr P Gopinath
IIT Roorkee Professor Dr P Gopinath discusses about developing an economical and green way to detect and kill cancer cells and how…
Changes during aging in elderly persons
Dr Samir Mashelkar, Consultant-Life Science, Pharma,Biotech, discusses the damage caused by free radicals and how several heart…
Plasticell wins military contract to develop regenerative medicines for the battlefield
Both trials are testing Xtandi in men with hormone-sensitive prostate cancer
Pfizer, Astellas revise two cancer drug trial protocols to speed up results
Both trials are testing Xtandi in men with hormone-sensitive prostate cancer
Moderate ‘bad cholesterol’ levels tied to early death for healthy people
Researchers examined data on 36,375 adults with no history of heart disease or diabetes and a low 10-year risk for events like…
Staying fit might cut glaucoma risk: Study
The study was not designed to determine whether or how exercise or physical fitness may directly influence glaucoma risk
Earlier onset of type 1 diabetes linked to greater heart risk, shorter life
27,195 individuals aged 18 years and older in the Swedish National Diabetes Register who had been diagnosed with type 1 diabetes…
Aptamers in cancer therapeutics
Dr Harleen Kaur,Senior Scientist, AstraZeneca USA, through her research paper, talks about collaborative approaches which can…
Genome editing using CRISPR-Cas9 system shows tremendous promise
Research published in Nature Medicine describes collaborative effort to reduce off-target CRISPR-Cas9 genome editing, removing…
Eisai/Biogen to advance Alzheimer’s drug, provide fresh hope
According to Eisai, the company had already contacted various regulators and plans to pursue accelerated approvals
US FDA approves Krintafel for radical cure of P. vivax malaria
First single-dose medicine to prevent the relapse of P. vivax malaria marks a major contribution towards malaria eradication…
Verseon presents anticancer drug candidates targeting multidrug resistant cancers
Verseon’s drug candidates target cancer cells by inhibiting the protein tubulin, which leads to cell cycle arrest